Centogene N.V. Stock

Stocks

39K

NL0014040206

Internet Services

OTC Markets Traded
End-of-day quote Hanseatische Wertpapierboerse Hamburg 2026-05-21 5-day change 1st Jan Change
0.1100 EUR -1.79% Intraday chart for Centogene N.V. -.--% +15.79%
3 months-1.79%
6 months+15.79%

Valuation: Centogene N.V.

Market Cap 2.61M 3.02M 2.44M 2.24M 4.21M 287M 4.27M 28.6M 11.22M 144M 11.33M 11.08M 476M P/E 2022
-2.24x
P/E 2023 -2.1x
Enterprise Value 63.85M 73.82M 59.63M 54.7M 103M 7.03B 105M 700M 275M 3.52B 277M 271M 11.64B EV / Sales 2022
2.03x
EV / Sales 2023 2.79x
Free-Float
95.16%
Yield 2022 *
-
Yield 2023 -
1 day-1.79%
3 months-1.79%
6 months+15.79%
Current year+15.79%
Current year 0.09
Extreme 0.0915
0.12
1 year 0.09
Extreme 0.0902
0.18
3 years 0.02
Extreme 0.021
0.3
5 years 0.02
Extreme 0.021
3.84
10 years 0.02
Extreme 0.021
3.84
Manager TitleAgeSince
Chief Executive Officer - 2025-02-03
Director of Finance/CFO - -
Chief Operating Officer 56 2015-12-31
Director TitleAgeSince
Chairman 59 2017-06-30
Director/Board Member 48 2018-12-31
Director/Board Member 70 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-.--%+17.02%-95.87% 3.79M
-0.08%+0.76%-15.56%+40.33% 548B
+0.61%+3.39%-37.19%+68.21% 309B
+6.46%+6.62%-19.05%+66.90% 153B
+17.43%+17.52%+48.35%+24.35% 105B
+3.16%+6.29%-16.21%+37.82% 104B
+2.75%-2.36%-28.92%+243.78% 100B
+1.41%+10.25%-20.20%+156.35% 93.7B
-3.20%-9.54%+561.73%+1,941.30% 87.74B
+3.83%+5.14%-18.76%+33.46% 42.53B
Average +0.60%+3.44%+47.12%+251.66% 154.29B
Weighted average by Cap. +0.55%+3.27%+15.66%+175.47%

Financials

2022 2023
Net sales 47.47M 54.88M 44.33M 40.67M 76.49M 5.22B 77.71M 520M 204M 2.62B 206M 202M 8.66B 48.54M 56.11M 45.33M 41.58M 78.21M 5.34B 79.45M 532M 209M 2.68B 211M 206M 8.85B
Net income -31.84M -36.81M -29.73M -27.28M -51.3M -3.5B -52.12M -349M -137M -1.76B -138M -135M -5.81B -35.53M -41.08M -33.18M -30.44M -57.25M -3.91B -58.16M -389M -153M -1.96B -154M -151M -6.48B
Net Debt 24.17M 27.94M 22.57M 20.71M 38.95M 2.66B 39.56M 265M 104M 1.33B 105M 103M 4.41B 61.24M 70.8M 57.19M 52.46M 98.67M 6.74B 100M 671M 263M 3.38B 266M 260M 11.16B
Logo Centogene N.V.
Crown LiquidationCo NV in liquidatie, is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Employees
384

Net sales - Rate of surprise